|
NSRX Nasus Pharma Ltd 2029039 |
| Balance Sheet |
|
Current Assets
|
$4,855,000.00 |
|
Assets
|
$5,004,000.00 |
|
Current Liabilities
|
$2,163,000.00 |
|
Liabilities
|
$2,236,000.00 |
|
Equity
|
$2,768,000.00 |
|
Shares Out
|
9015383.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,918,000.00 |
|
Investing Cash Flow
|
$-3,014,000.00 |
| Market Analysis |
Market Cap
|
$33,717,532.42 |
|
Price
|
$3.53 |
|
BVPS
|
0.31 |
|
PB
|
12.06 |
|
EPS
|
-0.72 |
|
PS
|
0.03 |
|
FCF
|
$-4,932,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:46 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NSRX documents filed with the SEC.
NSRX Filings
Clear
